Potent drug supply drop, not domestic drug policies, likely behind 2018 OD death downturn

September 16, 2020

PITTSBURGH, Sept. 16, 2020 - The slight decline in drug overdose deaths in 2018 coincided with changing Chinese regulations on a powerful type of opioid, rather than the result of U.S. efforts to curb the overdose epidemic, a University of Pittsburgh Graduate School of Public Health analysis revealed today in the journal Addiction.

What many--including President Donald Trump--perceived as a decline in overdose deaths in 2018 appears to be a return to the historic exponential curve. The finding is backed by preliminary federal data showing that the overdose death rate last year snapped back onto its long-term growth pattern, tallying more than 1 million deaths in the U.S. in the past four decades.

"The U.S. has not bent the curve on the drug overdose epidemic," said lead author Hawre Jalal, M.D., Ph.D., assistant professor of health policy and management at Pitt Public Health. "We are concerned that policymakers may have interpreted the one-year downturn in 2018 as evidence for an especially effective national response or the start of a long-term trend. Unfortunately, that isn't supported by the data."

Pitt Public Health scientists had previously demonstrated that overdose deaths have fit on an exponential curve since at least 1979, with the number of deaths doubling every 10.7 years. In 2016 and 2017, the death rate exceeded the curve's prediction by 22% and 11%, respectively. But in 2018, the rate declined by 4.1%, the first drop in overdose deaths since 1990.

Curious about what drove the drop, Jalal and Donald Burke, M.D., former dean of Pitt Public Health, crossed drug overdose data from the U.S. Centers for Disease Control and Prevention (CDC) with U.S. Drug Enforcement Administration (DEA) information on the types of drugs seized and submitted to state crime labs.

Carfentanil, an opioid that is 10,000 times more powerful than morphine and has no known medical use in humans, was rarely detected by these labs before 2016, when it began popping up in law enforcement drug seizures, peaking in 2017 and suddenly declining in 2018. The 2017 spike was concentrated in five states: Ohio, Florida, Pennsylvania, Kentucky and Michigan.

In 2017, China added carfentanil to its list of controlled substances, and, shortly thereafter, the U.S. supply dried up, coinciding with 2018's drop in overdose deaths.

When Jalal and Burke looked at the total decline in overdose deaths in just those five states with the largest decline in carfentanil drug seizures, they found that they accounted for nearly 100% of the total national drop in overdose deaths in 2018. Provisional 2019 data from the CDC shows a 5.6% rebound in overdose deaths since then.

"We all celebrated when the overdose death rate dropped, but it was premature," said Burke, Distinguished University Professor of Health Science and Policy in Pitt Public Health's Department of Epidemiology. "When policymakers believe a problem is solved, history has shown that funding is reprioritized to other efforts. The drug overdose epidemic is not solved. It continues to track along an ever-rising curve, with deaths doubling nearly every decade. We must address the root causes of this epidemic."

Jalal and Burke noted that the COVID-19 pandemic is likely to drive higher overdose deaths, especially since they tend to follow job losses, and social distancing means people may overdose alone, decreasing their chances of receiving life-saving care.

"This is a particularly critical time for the drug overdose epidemic, given the diversion of health care resources and the national attention to the COVID-19 pandemic," Jalal said. "The epidemic has continued brewing under the COVID-19 pandemic for half a year now. There is no indication that it's slowing."
This research was supported by National Institutes of Health grant K01DA048985.

To read this release online or share it, visit https://www.upmc.com/media/news/091620-jalal-burke-carfentanil [when embargo lifts].

About the University of Pittsburgh Graduate School of Public Health

The University of Pittsburgh Graduate School of Public Health, founded in 1948 and now one of the top-ranked schools of public health in the United States, conducts research on public health and medical care that improves the lives of millions of people around the world. Pitt Public Health is a leader in devising new methods to prevent and treat cardiovascular diseases, HIV/AIDS, cancer and other important public health problems. For more information about Pitt Public Health, visit the school's Web site at http://www.publichealth.pitt.edu.


University of Pittsburgh

Related Death Rate Articles from Brightsurf:

Death rate dramatically less for young heart attack survivors who quit smoking
Among young people who have had a heart attack, quitting smoking is associated with a substantial benefit.

Statin use is linked to lower death rate in hospitalized COVID-19 patients
The use of cholesterol-lowering drugs called statins is associated with a lower death rate and a lower incidence of mechanical ventilation in patients hospitalized with Coronavirus disease 2019 (COVID-19), researchers report June 24 in Cell Metabolism.

No improvement in death rate for COVID-19 patients who received hydroxychloroquine
A research team led by investigators from Brigham and Women's Hospital has evaluated real-world evidence related to outcomes for COVID-19 patients who were treated with hydroxychloroquine or chloroquine analogues (with or without a macrolide).

COVID-19: UW study reports 'staggering' death rate in US among those infected who show symptoms
New study finds the national rate of death among people infected with the novel coronavirus -- SARS-CoV-2 -- that causes COVID-19 and who show symptoms is 1.3%, the study found.

COVID-19 study shows that men have over double the death rate of women
COVID-19 has drastically different effects on the infected, with some people displaying no symptoms, while others can die.

SLE Medicaid patients have higher 30-day death rate compared to those with diabetes
New research found that the 30-day death rate for Medicaid patients with systemic lupus erythematosus (SLE) who underwent coronary revascularization procedures for cardiovascular disease was double that of patients with diabetes mellitus who underwent the same procedures.

Living through Katrina associated with higher death rate among breast cancer patients
Breast cancer patients who endured Hurricane Katrina in 2005 have a 15% higher mortality rate than those patients not exposed to the storm, according to a University of Michigan researcher.

Decades-long drop in breast cancer death rate continues
A decades-long decline in the breast cancer death rate continues, but has begun to slow in recent years.

Child death rate linked to hospital preparedness for pediatric emergencies
Critically ill children brought to hospital emergency departments that are ill-prepared to care for pediatric emergencies have more than three times the odds of dying compared to those brought to hospitals well-equipped to care for them.

Optimizing fertilizer source and rate to avoid root death
Study assembles canola root's dose-response curves for nitrogen sources.

Read More: Death Rate News and Death Rate Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.